Loading…
Lobbying Spend
—
Filings
24
Firms Hired
1
Active Period
2005–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Advocacy on biotechnology coverage, reimbursement issues, and Right To Try legislation, including S. 2192 and H.R. 3012
Client expense: — · Firm income: $15,000
Matched citations: H.R. 3012
NICS Reporting Improvement Act
2016 · fourth_quarter · Firm: KING & SPALDING LLP
Advocacy on biotechnology coverage, reimbursement issues, and Right To Try legislation, including S. 2192 and H.R. 3012
Client expense: — · Firm income: $15,000
Matched citations: S. 2192
Advocacy on biotechnology coverage, reimbursement issues, and Right To Try legislation, including S. 2192 and H.R. 3012
Client expense: — · Firm income: $15,000
Matched citations: H.R. 3012
Advocacy on biotechnology coverage, reimbursement issues, and Right To Try legislation, including S. 2192 and H.R. 3012
Client expense: — · Firm income: $15,000
Matched citations: S. 2192
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · first_quarter · Firm: THE WERNER GROUP
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
Client expense: — · Firm income: $20,000
Matched citations: HR 1427
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
Client expense: — · Firm income: $20,000
Matched citations: HR 1548
HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Newborn Screening Saves Lives Act of 2007
2008 · second_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 1634
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Newborn Screening Saves Lives Act of 2007
2008 · second_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1858
Newborn Screening Saves Lives Act of 2007
2008 · second_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: S. 634
Newborn Screening Saves Lives Act of 2007
2008 · first_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 1634
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Newborn Screening Saves Lives Act of 2007
2008 · first_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: S. 1858
Newborn Screening Saves Lives Act of 2007
2008 · first_quarter · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Client expense: — · Firm income: $30,000
Matched citations: S. 634
Newborn Screening Saves Lives Act of 2008
2008 · first_quarter · Firm: THE WERNER GROUP
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Client expense: — · Firm income: —
Matched citations: HR 3825
Newborn Screening Saves Lives Act of 2008
2008 · first_quarter · Firm: THE WERNER GROUP
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Client expense: — · Firm income: —
Matched citations: HR 3825
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Client expense: — · Firm income: —
Matched citations: HR 5629
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Client expense: — · Firm income: —
Matched citations: HR 5629
Source: Senate LDA